While 74.2% of primary ESCC tumors showed elevated vimentin expression, the incidence of lymph node metastasis was reported in 71.9% of vimentin-positive tumors compared to 35.5% in vimentin-negative ESCC tumors. The gene discussed is VIM; the disease is metastatic malignant neoplasm in the lymph nodes.